Myasthenia gravis (MG) is a chronic and often debilitating autoimmune disorder of the neuromuscular junction characterized by muscle weakness and fatigue. MG is caused by antibodies against the ...

UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies ...

Imaavy shows sustained generalized myasthenia gravis (gMG) symptom control through week 24: In indirect comparisons, Imaavy (nipocalimab-aahu) consistently outperformed other approved FcRn blockers in ...

Stroke Thyroid ophthalmopathy Patient Case: Generalized myasthenia gravis By By Daniel DiCapua, MD, FAAN, Yale University, New Haven, CT Images by Stacy Gray Published: June 30, 2025 ...

China’s National Medical Products Administration (NMPA) recently approved telitacicept (RemeGen), an investigational agent, for the treatment of adult patients with anti–acetylcholine receptor ...

Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental issues like puberty that are not present in adult disease.

ATLANTA, June 17, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia ...

UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's ...

OTTAWA — Established treatments such as thymectomy and steroids remain mainstays in the management of myasthenia gravis (MG), according to a presentation at the Canadian Neurological Sciences ...

Johnson & Johnson (NYSE: JNJ) today announced new data from an indirect treatment comparison (ITC) that showed consistent and sustained disease control with IMAAVY™ (nipocalimab-aahu) versus ...

Myasthenia gravis causes fatigue and muscle weakness, double vision, slurred speech, and difficulty with chewing, swallowing and making facial expressions.

Myasthenia gravis causes fatigue and muscle weakness, double vision, slurred speech, and difficulty with chewing, swallowing and making facial expressions. "If you weigh up the cost of the drug ...